Using a Tobacco Heating System to Treat Chronic Generalized Periodontitis: Protocol for a Randomized, Controlled, Multicenter Study

Studies comparing smokers and nonsmokers found that smoking is a significant risk factor for the development of periodontal disease and the loss of a tooth. People who have quit smoking had a greater probability of reversing periodontal disease after nonsurgical treatment, despite the fact that only a few studies have studied the long-term prognosis of periodontal disease after stopping smoking. The use of less harmful tobacco products in lieu of cigarettes may help smokers who otherwise want to continue their habit. Efforts to decrease the harmful health impacts of tobacco usage include this method. Heat-not-burn products include Philip Morris International's Tobacco Heating System (THS), which is currently offered under the IQOS brand name.

Instead of burning tobacco, the iqos smokeless gadget warms it electrically, at lower temperatures than those seen in cigarettes. As a consequence, there are many less toxic and possibly hazardous elements produced, but the nicotine, flavour, ritual, and sensory experience are all equivalent to those of traditional cigarettes in this alternative method. The results of a rigorous clinical evaluation programme have been released by Philip Morris International. Adult smokers who transition from smoking cigarettes to using the THS are expected to have a lower chance of developing health complications as a result of this study. Tobacco-related illnesses among adult smokers are being covered by the project, which is making progress.

Patients with chronic periodontitis who have completely quit smoking cigarettes are compared to those who continue to smoke cigarettes as a control group.

Research was conducted in Japan on individuals with chronic periodontitis who had converted from cigarettes to THS for six months and compared to those who continued to smoke cigarettes for the same amount of time. Mechanical periodontal therapy was administered to the patients in compliance with Japanese medical standards. Study participants will be asked to compare the reduction in pocket depth (PD) in all places with a baseline PD of less than 4 millimetres after switching from cigarette smoking to THS use. As an added benefit, this research will look for other periodontal indicators, such a patient's clinical attachment level or gingival inflammation, as well as gauge how well they're doing after switching to THS. Throughout the whole experiment, the safety of the participants was closely monitored.